Add Formweb to your mobile device
Formulary synchronization in progress.
Please refer to Epic and your local
pharmacy
for available medications.
Search results for:
esketamine
esketamine
- Provider restrictions: Restricted to attending level psychiatry providers
- Patient restrictions: Restricted to patients enrolled in the Spravato REMS program who have financial approval to continue SpravatoTM after hospital discharge
- Care Area restrictions: Restricted to hospitals enrolled the Spravato REMS program and patient care areas that can provide monitoring by psychiatry trained nurses for at least 2 hours following each dose
Brand names: Spravato
| Form | Strength |
|---|---|
| DEVICE, NASAL | 28 mg |
Last updated: Aug. 24, 2022
- Black Box Warnings: Sedation; Dissociation; Abuse and Misuse; and Surcidal Thoughts and Behaviors
- FDA REMS: View FDA REMS Info
- FDA REMS: FDA Med Guide Comprehensive List
Policies and procedures
System_RXP&T 108 Medication Risk Evaluation and Mitigation Strategy (REMS) Management
Spravato REMS Program
Consults, protocols, and therapeutic interchanges
Additional information